Cargando…

Evolution of systemic therapy for advanced-stage hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Hur, Moon Haeng, Kim, Yoon Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745626/ https://www.ncbi.nlm.nih.gov/pubmed/36523933 http://dx.doi.org/10.21037/hbsn-22-507

Ejemplares similares

How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
por: Kim, Beom Kyung
Publicado: (2023)

All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Development of conversion therapy for advanced hepatocellular carcinoma
por: Matsuki, Ryota, et al.
Publicado: (2023)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2020)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report
por: Hur, Moon Haeng, et al.
Publicado: (2022)

Approach to systemic therapy in advanced hepatocellular carcinoma
por: Sankar, Kamya, et al.
Publicado: (2022)

The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
por: Hur, Moon Haeng, et al.
Publicado: (2023)

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
por: Eso, Yuji
Publicado: (2020)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Is the Barcelona Clinic Liver Cancer guideline for treating intermediate to advanced staged hepatocellular carcinoma still appropriate?
por: Kang, Koo Jeong, et al.
Publicado: (2021)

Systemic therapy in advanced hepatocellular carcinoma
por: Ahn, Joseph C., et al.
Publicado: (2023)

Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma
por: Lee, Ahlim, et al.
Publicado: (2022)

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
por: Han, Sojung, et al.
Publicado: (2020)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy
por: Yoon, Sang Min
Publicado: (2023)

Novel Therapies for Hepatocellular Carcinoma
por: Rimassa, Lorenza
Publicado: (2020)

Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
por: Aitcheson, Gabriella, et al.
Publicado: (2021)

Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success
por: Da Fonseca, Leonardo G., et al.
Publicado: (2018)

Which treatment modality should we choose for advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2010)

Recent advances in systemic therapy for hepatocellular carcinoma
por: Zhang, Huajun, et al.
Publicado: (2022)

Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
por: Kudo, Masatoshi
Publicado: (2018)

Pro-senescence therapy for hepatocellular carcinoma
por: Muehlich, Susanne, et al.
Publicado: (2013)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

Evolution of Guidelines for Testosterone Replacement Therapy
por: Park, Hyun Jun, et al.
Publicado: (2019)

Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022?
por: Wong, Jeffrey Sum Lung, et al.
Publicado: (2023)

Precision oncology and molecular therapies for hepatocellular carcinoma
por: Chen, Liming, et al.
Publicado: (2022)

Hepatocellular Carcinoma: Carcinogenesis, Establishment, Progression, and Therapies
por: Guan, Yong-Song, et al.
Publicado: (2014)

Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis
por: Choi, Na Ryung, et al.
Publicado: (2022)

Recent Advances in Bioinformatics Reveal the Molecular Heterogeneity of Hepatocellular Carcinoma
Publicado: (2014)

What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
por: Park, Min Kyung, et al.
Publicado: (2023)

Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy
por: Goh, Myung Ji, et al.
Publicado: (2020)

Recent advances in the imaging of hepatocellular carcinoma
por: You, Myung-Won, et al.
Publicado: (2015)

Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity
por: Kudo, Masatoshi
Publicado: (2023)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
por: Hur, Moon Haeng, et al.
Publicado: (2023)

Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma
por: Tazi, El Mehdi, et al.
Publicado: (2011)

Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma
por: Zhou, Kehua, et al.
Publicado: (2019)

Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives
por: Girardi, Daniel M., et al.
Publicado: (2023)

Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
por: Moriya, Kei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_31hq3kclbf3i3d0ov7hjg8g880